Multiple Endocrine Neoplasms in a Patient with AL Amyloidosis-Associated Plasma Cell Dyscrasia
- PMID: 12114636
- DOI: 10.1007/BF02739944
Multiple Endocrine Neoplasms in a Patient with AL Amyloidosis-Associated Plasma Cell Dyscrasia
Abstract
Reports on patients with systemic amyloidosis-associated plasma cell dyscrasia (PCD) who have multiple endocrine tumors are very rare. Here we describe such a case. The patient was a 74-yr-old man with amyloid light-chain (AL) amyloidosis-associated PCD who had a null-cell adenoma of the pituitary and a latent papillary carcinoma of the thyroid gland. as well as a tubular adenoma of the sigmoid colon. The amyloid protein deposits reacted with the antibody to the n-immunoglobulin light chain. Since PCD by itself may be a risk factor for the development of subsequent neoplasms, the careful clinical evaluation of PCD patients is recommended.
Similar articles
-
Evaluation of multinodular goiter and primary hyperparathyroidism leads to a diagnosis of AL amyloidosis.Thyroid Res. 2022 Apr 20;15(1):7. doi: 10.1186/s13044-022-00125-5. Thyroid Res. 2022. PMID: 35440089 Free PMC article.
-
Plasma cell dyscrasia in 105 Japanese patients with systemic amyloidosis.Jpn J Med. 1983 Apr;22(2):117-21. doi: 10.2169/internalmedicine1962.22.117. Jpn J Med. 1983. PMID: 6865104
-
Coexistence of beta2 microglobulin and lambda light chain in amyloid fibrils of dialysis-unrelated plasma cell dyscrasia-associated systemic amyloidosis.Br J Dermatol. 2002 Sep;147(3):549-53. doi: 10.1046/j.1365-2133.2002.04940.x. Br J Dermatol. 2002. PMID: 12207599
-
Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis.Contrib Nephrol. 2007;153:195-210. doi: 10.1159/000096768. Contrib Nephrol. 2007. PMID: 17075231 Review.
-
Amyloidosis.Curr Treat Options Oncol. 2006 May;7(3):225-36. doi: 10.1007/s11864-006-0015-8. Curr Treat Options Oncol. 2006. PMID: 16615878 Review.
References
LinkOut - more resources
Full Text Sources